Walmart to Join Nasdaq-100 Index as It Replaces AstraZeneca Following Exchange Move 
Chevron Sees Path to Boost Venezuela Oil Output by 50% After Trump Administration Talks 
Avelo Airlines to End DHS Deportation Flights and Close Arizona Base Amid Rising Costs 
AustralianSuper Backs BlueScope Steel’s Rejection of $9 Billion Takeover Bid 
xAI Cash Burn Highlights the High Cost of Competing in Generative AI 
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan 
Hyundai Motor Shares Surge on Nvidia Partnership Speculation 
OpenAI Sets $50 Billion Stock Grant Pool, Boosting Employee Equity and Valuation Outlook 
Stellantis to End Plug-In Hybrid Sales in the U.S. as Demand Shifts Toward Traditional Hybrids 
EU Orders Elon Musk’s X to Preserve Grok AI Data Amid Probe Into Illegal Content 
SK Hynix Shares Hit Record High as AI Memory Demand Fuels Semiconductor Rally 
Aktis Oncology Prices Upsized IPO at $18, Raising $318 Million in Major Biotech Debut 
GM Takes $6 Billion EV Write-Down as Electric Vehicle Demand Slows in the U.S. 
FCC Exempts Select Foreign-Made Drones From U.S. Import Ban Until 2026 
FTC Blocks Edwards Lifesciences’ JenaValve Acquisition in Major Antitrust Ruling 
Boeing 737 MAX 10 Advances in FAA Testing as Certification Delays Continue 
NORWALK, Conn., Oct. 24, 2017 -- Animal Cancer Foundation (ACF), a national non-profit organization that supports comparative oncology research that studies the similarities between naturally occurring cancers in people and pets to find cures for both species, is proud to announce a $1 million dollar gift by long-time benefactor The Blue Buffalo Foundation to support the Canine Cancer Genome Project (CCGP). The CCGP project seeks to map the tumor genomes of the most common canine cancers, a missing piece of information cancer researchers need to expedite research to benefit pets and people.
|
|||
One-in-four dogs develops naturally occurring cancer in its lifetime compared with one in three women and one in two men. The most common cancers in our pets are also very common in people, particularly children. Understanding the genetic makeup of canine cancer tumors, and comparing their genetic makeup to those of people with cancer, will allow researchers to discover additional targeted drug therapies and the least toxic doses of those therapies that are most effective in curing the individual, whether canine or human.
The initiative arose as a result of a review conducted in 2015 by the Institute of Medicine (IOM) of the National Academy of Science and supported in part by Animal Cancer Foundation that highlighted the value of comparative oncology and the inclusion of veterinary oncologists in accelerating cancer drug development.
Animal Cancer Foundation has assembled a scientific advisory council composed of leading experts in cancer genetics, drug development and comparative oncology to author a request for proposals for genomics laboratories capable of generating, analyzing and hosting the resulting data in the public domain, allowing researchers across disciplines access to refine clinical trials, and improving efficiency of drug development for all.
Animal Cancer Foundation has pledged to raise an additional $1 million in support of the project. The fundraising effort launched October 1 and is being supported by The Blue Buffalo Foundation which has partnered with ACF to supplement the reach of the organization, especially during its May is Pet Cancer Awareness Month campaign.
“We are proud to support Animal Cancer Foundation in their important work helping to find ways to cure this terrible disease affecting pets,” said David Petrie, President, Blue Buffalo Foundation.
“We are thankful to the Blue Buffalo Foundation and their millions of donors nationwide for their support to help us further our mission. The Canine Cancer Genome Project will help to fill a resource gap in cancer research for our beloved family members, people and pets, that are battling the disease,” said Barbara Cohen, Executive Director of Animal Cancer Foundation. “We look forward to raising the additional funds needed to get this important genetic information into the hands of cancer researchers.”
For more information visit: www.ACFoundation.org/CCGP
About The Blue Buffalo Foundation
The Blue Buffalo Foundation was established in 2004 by the founders of Blue Buffalo, a manufacturer of natural dog and cat foods under the BLUE™ brand name. In alignment with our mission of enhancing the lives of the pets who bring us so much joy, we created the Blue Buffalo Foundation. A nonprofit charitable organization, the Foundation encompasses a variety of programs intended to improve the lives of our furry friends and the pet parents who love them by funding cancer research, providing financial assistance for cancer treatments, veterinary scholarships, and support to organizations that supply service dogs to disabled military personnel. For more information visit BlueBuffaloFoundation.org.
About Animal Cancer Foundation
Animal Cancer Foundation is a 501(c)(3) organization dedicated to finding novel treatment therapies and eventual cures for cancer by funding research in and increasing public awareness of comparative oncology, the study of naturally occurring cancers in pets and people to benefit both. Founded by Gerald S. Post, DVM, MEM, Diplomate ACVIM (Oncology) in October 1999, Animal Cancer Foundation is based in Norwalk, CT. For more information visit www.acfoundation.org
Contact:
Barbara Cohen, Executive Director
Animal Cancer Foundation
(T) 917-612-4514
(E): [email protected]
